Nivolumab Improves Sorafenib-Treated Liver Cancer Nivolumab Improves Sorafenib-Treated Liver Cancer
Nivolumab immunotherapy could provide a durable response, and increase survival, for patients with advanced hepatocellular carcinoma who do not respond completely to sorafenib, new research shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Gastroenterology | Health | Hepatocellular Carcinoma | Immunotherapy | Liver | Liver Cancer | Urology & Nephrology